Safe de-escalation of chemotherapy in HER2-positive early breast cancer. Earl HM. Lancet 2024 Apr 3:S0140-6736(24)00535-X. doi: 10.1016/S0140-6736(24)00535.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Earl HM. Safe de-escalation of chemotherapy in HER2-positive early breast cancer. Lancet 2024 Apr 3:S0140-6736(24)00535-X. doi: 10.1016/S0140-6736(24)00535.
PMID: 38582093